[1]
|
O. R?tzschke and K. Falk, “Origin, Structure and Motifs of Naturally Processed MHC Class II Ligands,” Current Opinion in Immunology, Vol. 6, No. 1, February 1994, pp. 45-51. doi:10.1016/0952-7915(94)90032-9
|
[2]
|
J. Robinson, M. J. Waller, P. Parham, N. De Groot, R. Bontrop, L. J. Kennedy, P. Stoehr and S. G. E. Marsh, “IMGT/HLA and IMGT/MHC: Sequence Databases for the Study of the Major Histocompatibility Complex,” Nucleic Acids Research, Vol. 31, No. 1, 2003, pp. 311- 314. doi:10.1093/nar/gkg070
|
[3]
|
A. Dessen, C. M. Lawrence, S. Cupo, D. M. Zaller and D. C. Wiley, “X-Ray Crystal Structure of HLA-DR4 (DRA* 0101, DRB1*0401) Complexed with a Peptide from Human Collagen II,” Immunity, Vol. 7, No. 4, October 1997, pp. 473-481.
doi:10.1016/S1074-7613(00)80369-6
|
[4]
|
Z. Zavala-Ruiz, E. J. Sundberg, J. D. Stone, D. B. DeOliveira, I. C. Chan, J. Svendsen, R. A. Mariuzza and L. J. Stern, “Exploration of the P6/P7 Region of the Peptide- binding Site of the Human Class II Major Histocompatability Complex Protein HLA-DR1,” Journal of Biological Chemistry, Vol. 278, 2003, pp. 44904-44912.
doi:10.1074/jbc.M307652200
|
[5]
|
Z. Zavala-Ruiz, I. Strug, B. D. Walker, P. J. Norris and L. J. Stern, “A Hairpin Turn in a Class II MHC-Bound Peptide Orients Residues outside the Binding Groove for T Cell Recognition,” Proceeding of National Acadademy of Sciences USA, Vol. 101, No. 36, 2004, pp. 13279-13284.
doi:10.1073/pnas.0403371101
|
[6]
|
M. M. Fernandez, R. Guan, C. P. Swaminathan, E. L. Malchiodi and R. A. Mariuzza, “Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human Major Histocompatibility Complex Class II Molecule,” Journal of Biological Chemistry, Vol. 281, 2006, pp. 25356-25364. doi:10.1074/jbc.M603969200
|
[7]
|
J. Hennecke and D. C. Wiley, “Structure of a Complex of the Human a/b T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA*0101 and DRB1*0401): Insight into TCR Cross-Restriction and Alloreactivity,” Journal of Experimental Medicine, Vol. 195, 2002, pp. 571-581. doi:10.1084/jem.20011194
|
[8]
|
L. Deng, R. J. Langley, P. H. Brown, G. Xu, L. Teng, Q. Wang, M. I. Gonzales, G. G. Callender, M. I. Nishimura, S. L. Topalian and R. A. Mariuzza, “Structural Basis for the Recognition of Mutant Self by a Tumor-Specific, MHC Class II-Restricted T Cell Receptor,” Nature Immunology, Vol. 8, 2007, pp. 398-408. doi:10.1038/ni1447
|
[9]
|
L. Wang, Y. Zhao, Z. Li, Y. Guo, L. L. Jones, D. M. Kranz, W. Mourad and H. Li, “Crystal Structure of a Complete Ternary Complex of TCR, Superantigen and Peptide-MHC,” Nature Structural & Molecular Biology, Vol. 14, 2007, pp. 169-171. doi:10.1038/nsmb1193
|
[10]
|
C. A. Janeway, P. Travers, M. Walport and J. D. Capra, “Immunobiology: The Immune System in Health and Disease,” Elsevier Science Ltd., 1999.
|
[11]
|
I. A. Doytchinova and D. R. Flower, “Towards the in Silico Identification of Class II Restricted T-Cell Epitopes: a Partial Least Squares Iterative Self-Consistent Algorithm for Affinity Prediction,” Bioinformatics, Vol. 19, No. 17, 2003, pp. 2263-2270.
doi:10.1093/bioinformatics/btg312
|
[12]
|
J. C. Tong, G. L. Zhang, T. W. Tan, J. T. August, V. Brusic and S. Ranganathan, “Prediction of HLA-DQ3.2β Ligands: Evidence of Multiple Registers in Class II Binding Peptides,” Bioinformatics, Vol. 22, No. 10, 2006, pp. 1232-1238. doi:10.1093/bioinformatics/btl071
|
[13]
|
H. H. Lin, G. L. Zhang, S. Tongchusak, E. L. Reinherz and V. Brusic, “Evaluation of MHC-II Peptide Binding Prediction Servers: Applications for Vaccine Research,” BMC Bioinformatics, Vol. 9, 2008, Suppl. 12, S22.
|
[14]
|
R. R. Mallios, “A Consensus Strategy for Combining HLA-DR Binding Algorithms,” Human Immunology, Vol. 64, No. 9, September 2003, pp. 852-856.
doi:10.1016/S0198-8859(03)00142-3
|
[15]
|
H. Rammensee, J. Bachmann, N. P. Emmerich, O. A. Bachor and S. Stevanovic, “SYFPEITHI: Database for MHC Ligands and Peptide Motifs,” Immunogenetics, Vol. 50, No. 3-4, 1999, pp. 213-219.
doi:10.1007/s002510050595
|
[16]
|
H. Singh and G. P. Raghava, “ProPred: Prediction of HLA-DR Binding Sites,” Bioinformatics, Vol. 17, No. 12, 2001, pp. 1236-1237.
doi:10.1093/bioinformatics/17.12.1236
|
[17]
|
R. R. Mallios, “Predicting Class II MHC/Peptide Multi- Level Binding with an Iterative Stepwise Discriminant Analysis Meta-Algorithm,” Bioinformatics, Vol. 17, No. 10, 2001, pp. 942-948.
doi:10.1093/bioinformatics/17.10.942
|
[18]
|
G. L. Zhang, A. M. Khan, K. N. Srinivasan, J. T. August and V. Brusic, “Neural Models for Predicting Viral Vaccine Targets,” Journal of Bioiformatics and Computational Biology, Vol. 3, No. 5, 2005, pp. 1207-1225.
doi:10.1142/S0219720005001466
|
[19]
|
O. Karpenko, L. Huang and Y. Dai, “A Probabilistic Meta-Predictor for the MHC Class II Binding Peptides,” Immunogenetics, Vol. 60, No. 1, 2008, pp. 25-36.
doi:10.1007/s00251-007-0266-y
|
[20]
|
P. Wang, J. Sidney, C. Dow, B. Mothe, A. Sette and B. Peters, “A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach,” PLoS Computational Biology, Vol. 4, 2008, p. e1000048. doi:10.1371/journal.pcbi.1000048
|
[21]
|
P. A. Reche, J. P. Glutting and E. L. Reinherz, “Enhancement to the RANKPEP Resource for the Prediction of Peptide Binding to MHC Molecules Using Profiles,” Immunogenetics, Vol. 56, No. 6, 2004, pp. 405-419.
doi:10.1007/s00251-004-0709-7
|
[22]
|
M. Nielsen, C. Lundegaard, T. Blicher, B. Peters, A. Sette, S. Justesen, S. Buus and O. Lund, “Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan,” PLoS Computational Biology, Vol. 4, 2008, p. e1000107.
|
[23]
|
M. Nielsen and O. Lund, “NN-Align: An Artificial Neural Network-Based Alignment Algorithm for MHC Class II Peptide Binding Prediction,” BMC Bioinformatics, Vol. 10, 2009, p. 296. doi:10.1186/1471-2105-10-296
|
[24]
|
I. Dimitrov, P. Garnev, D. R. Flower and I. Doytchinova, “Peptide Binding to the HLA-DRB1 Supertype: A Proteochemometrics Analysis,” European Journal of Medicinal Chemistry, Vol. 45, No. 1, January 2010, pp. 236- 243. doi:10.1016/j.ejmech.2009.09.049
|
[25]
|
I. Dimitrov, P. Garnev, D. R. Flower and I. Doytchinova, “EpiTOP—A Proteochemometric Tool for MHC Class II Binding Prediction,” Bioinformatics, Vol. 26, No. 16, 2010, pp. 2066-2068. doi:10.1093/bioinformatics/btq324
|
[26]
|
I. Dimitrov, P. Garnev, D. R. Flower and I. Doytchinova, “MHC Class II Binding Prediction: A Little Help from a Friend,” Journal of Biomedicine and Biotechnology, Vol. 2010, Special Issue Vaccine Informatics, 2010, Article ID705821.
|
[27]
|
B. Peters and A. Sette, “Integrating Epitope Data into the Emerging Web of Biomedical Knowledge Resources,” Nature Reviews Immunology, Vol. 7, June 2007, pp. 485- 490. doi:10.1038/nri2092
|
[28]
|
T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia and J. Hammer, “Generation of Tissue-Specific and Promiscuous HLA Ligand Databases Using DNA Microarrays and Virtual HLA Class II Matrices,” Nature Biotechnology, Vol. 17, June 1999, pp. 555-561.
doi:10.1038/9858
|
[29]
|
D. R. Flower, “Vaccines: Data Driven Prediction of Binders, Epitopes and Immunogenicity. Bioinformatics for Vaccinology,” Wiley-Blackwell, 2008.
|
[30]
|
K. C. Parker, M. A. Bednarek and J. E. Coligan, “Scheme for Ranking Potential HLA-A2 Binding Peptides Based on Independent Binding of Individual Peptide Side- Chains,” Journal of Immunology, Vol. 152, No. 1, 1994, pp. 163-175.
|
[31]
|
M. Pawlowski, M. J. Gajda, R. Matlak and J. M. Bujnicki, “MetaMQAP: A Meta-Server for the Quality Assessment of Protein Models,” BMC Bioinformatics, Vol. 9, 2008, p. 403. doi:10.1186/1471-2105-9-403
|
[32]
|
B. Wallner, P. Larsson and A. Elofsson, “Pcons.Net: Protein Structure Prediction Meta Server,” Nucleic Acids Research, Vol. 35 (Web Server Issue), 2007, pp. W369-374.
|
[33]
|
I. Friedberg, T. Harder and A. Godzik, “JAFA: A Protein Function Annotation Meta-Server,” Nucleic Acids Research, Vol. 34 (Web Server Issue), 2006, pp. W379-381.
|
[34]
|
O. Karpenko, L. Huang and Y. Dai, “A Probabilistic Meta-Predictor for the MHC Class II Binding Peptides,” Immunogenetics, Vol. 60, No. 1, 2008, pp. 25-36.
doi:10.1007/s00251-007-0266-y
|
[35]
|
B. Trost, M. Bickis and A. Kusalik, “Strength in Numbers: Achieving Greater Accuracy in MHC-I Binding Prediction by Combining the Results from Multiple Prediction Tools,” Immunome Research, Vol. 3, 2007, p. 5.
doi:10.1186/1745-7580-3-5
|